Astrea Pharma is a CDMO founded with the purpose of building a customer-focused manufacturing network covering development to commercial supply. They acquired the Fontaine-les-Dijon solid dose manufacturing site from Recipharm and offer oral solid dose and aseptic manufacturing capabilities from development through commercial supply, with a focus on efficiency and value in the pharma supply chain.
oral solid dose manufacturing, aseptic manufacturing, clinical to commercial supply, pharma supply chain efficiency
1 site worldwide
Involvement in 2 clinical trials
No reviews available yet.
No documents available.